Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 37

1.

Heparin-like polysaccharides reduce osteolytic bone destruction and tumor growth in a mouse model of breast cancer bone metastasis.

Pollari S, Käkönen RS, Mohammad KS, Rissanen JP, Halleen JM, Wärri A, Nissinen L, Pihlavisto M, Marjamäki A, Perälä M, Guise TA, Kallioniemi O, Käkönen SM.

Mol Cancer Res. 2012 May;10(5):597-604. doi: 10.1158/1541-7786.MCR-11-0482. Epub 2012 Apr 20.

PMID:
22522458
[PubMed - indexed for MEDLINE]
Free Article
2.

Molecular basis of requirement of receptor activator of nuclear factor κB signaling for interleukin 1-mediated osteoclastogenesis.

Jules J, Zhang P, Ashley JW, Wei S, Shi Z, Liu J, Michalek SM, Feng X.

J Biol Chem. 2012 May 4;287(19):15728-38. doi: 10.1074/jbc.M111.296228. Epub 2012 Mar 13.

PMID:
22416138
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Cancer to bone: a fatal attraction.

Weilbaecher KN, Guise TA, McCauley LK.

Nat Rev Cancer. 2011 Jun;11(6):411-25. doi: 10.1038/nrc3055. Epub 2011 May 19. Review.

PMID:
21593787
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

TGFβ-dependent induction of interleukin-11 and interleukin-8 involves SMAD and p38 MAPK pathways in breast tumor models with varied bone metastases potential.

Gupta J, Robbins J, Jilling T, Seth P.

Cancer Biol Ther. 2011 Feb 1;11(3):311-6. Epub 2011 Feb 1.

PMID:
21099351
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Receptor activator of NF-{kappa}B (RANK) cytoplasmic IVVY535-538 motif plays an essential role in tumor necrosis factor-{alpha} (TNF)-mediated osteoclastogenesis.

Jules J, Shi Z, Liu J, Xu D, Wang S, Feng X.

J Biol Chem. 2010 Nov 26;285(48):37427-35. doi: 10.1074/jbc.M110.149484. Epub 2010 Sep 24.

PMID:
20870724
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer.

Hanavadi S, Martin TA, Watkins G, Mansel RE, Jiang WG.

Ann Surg Oncol. 2006 Jun;13(6):802-8. Epub 2006 Apr 14.

PMID:
16614887
[PubMed - indexed for MEDLINE]
7.

COX-2 induces IL-11 production in human breast cancer cells.

Singh B, Berry JA, Shoher A, Lucci A.

J Surg Res. 2006 Apr;131(2):267-75. Epub 2006 Feb 2.

PMID:
16457848
[PubMed - indexed for MEDLINE]
8.

Breast cancer bone metastasis mediated by the Smad tumor suppressor pathway.

Kang Y, He W, Tulley S, Gupta GP, Serganova I, Chen CR, Manova-Todorova K, Blasberg R, Gerald WL, Massagué J.

Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13909-14. Epub 2005 Sep 19. Erratum in: Proc Natl Acad Sci U S A. 2006 May 30;103(22):8570.

PMID:
16172383
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Interleukin-11 receptor signaling is required for normal bone remodeling.

Sims NA, Jenkins BJ, Nakamura A, Quinn JM, Li R, Gillespie MT, Ernst M, Robb L, Martin TJ.

J Bone Miner Res. 2005 Jul;20(7):1093-102. Epub 2005 Feb 14.

PMID:
15940362
[PubMed - indexed for MEDLINE]
10.

IL-1 mediates TNF-induced osteoclastogenesis.

Wei S, Kitaura H, Zhou P, Ross FP, Teitelbaum SL.

J Clin Invest. 2005 Feb;115(2):282-90.

PMID:
15668736
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Human interleukin-1-induced murine osteoclastogenesis is dependent on RANKL, but independent of TNF-alpha.

Ma T, Miyanishi K, Suen A, Epstein NJ, Tomita T, Smith RL, Goodman SB.

Cytokine. 2004 May 7;26(3):138-44.

PMID:
15135808
[PubMed - indexed for MEDLINE]
12.

Mechanisms of bone metastasis.

Roodman GD.

N Engl J Med. 2004 Apr 15;350(16):1655-64. Review. No abstract available.

PMID:
15084698
[PubMed - indexed for MEDLINE]
13.

Breast cancer cells induce osteoclast formation by stimulating host IL-11 production and downregulating granulocyte/macrophage colony-stimulating factor.

Morgan H, Tumber A, Hill PA.

Int J Cancer. 2004 May 1;109(5):653-60.

PMID:
14999770
[PubMed - indexed for MEDLINE]
14.

RANK signaling is not required for TNFalpha-mediated increase in CD11(hi) osteoclast precursors but is essential for mature osteoclast formation in TNFalpha-mediated inflammatory arthritis.

Li P, Schwarz EM, O'Keefe RJ, Ma L, Boyce BF, Xing L.

J Bone Miner Res. 2004 Feb;19(2):207-13.

PMID:
14969390
[PubMed - indexed for MEDLINE]
15.

A multigenic program mediating breast cancer metastasis to bone.

Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordón-Cardo C, Guise TA, Massagué J.

Cancer Cell. 2003 Jun;3(6):537-49.

PMID:
12842083
[PubMed - indexed for MEDLINE]
Free Article
16.

Interleukin-6 and interleukin-11 support human osteoclast formation by a RANKL-independent mechanism.

Kudo O, Sabokbar A, Pocock A, Itonaga I, Fujikawa Y, Athanasou NA.

Bone. 2003 Jan;32(1):1-7.

PMID:
12584029
[PubMed - indexed for MEDLINE]
17.

Metastasis to bone: causes, consequences and therapeutic opportunities.

Mundy GR.

Nat Rev Cancer. 2002 Aug;2(8):584-93. Review.

PMID:
12154351
[PubMed - indexed for MEDLINE]
18.

Heterogeneous proliferative potential of occult metastatic cells in bone marrow of patients with solid epithelial tumors.

Solakoglu O, Maierhofer C, Lahr G, Breit E, Scheunemann P, Heumos I, Pichlmeier U, Schlimok G, Oberneder R, Kollermann MW, Kollermann J, Speicher MR, Pantel K.

Proc Natl Acad Sci U S A. 2002 Feb 19;99(4):2246-51.

PMID:
11854519
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Breast cancer increases osteoclastogenesis by secreting M-CSF and upregulating RANKL in stromal cells.

Mancino AT, Klimberg VS, Yamamoto M, Manolagas SC, Abe E.

J Surg Res. 2001 Sep;100(1):18-24.

PMID:
11516200
[PubMed - indexed for MEDLINE]
20.

Interleukins-6 and -11 expression in primary breast cancer and subsequent development of bone metastases.

Sotiriou C, Lacroix M, Lespagnard L, Larsimont D, Paesmans M, Body JJ.

Cancer Lett. 2001 Aug 10;169(1):87-95.

PMID:
11410329
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk